Received 08/22/2022 review began 02/28/2023 review ended 04/05/2023 published 04/09/2023

HIGHLIGHTS

  • who: Hospitalizations Away? et al. from the Medical College, Chinakakani, IND Medicine, California Institute of Neurosciences and Psychology have published the research work: Received 08/22/2022 Review began 02/28/2023 Review ended 04/05/2023 Published 04/09/2023, in the Journal: (JOURNAL) of April/09,/2023
  • what: In this review article, the authors focused on different papers to address the benefits of adding sacubitril/valsartan in reducing hospitalizations, hospital readmissions, and adverse effects, along with comparing the cost-benefit of the drug and prescribing optimal doses.
  • how: Intending to improve . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?